ORAGENICS INC
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation FL
Business Address 9015 TOWN CENTER PARKWAY, LAKEWOOD RANCH, FL, 34202
Mailing Address 9015 TOWN CENTER PARKWAY, LAKEWOOD RANCH, FL, 34202
Phone 8132867900
Fiscal Year End 1231
EIN 593410522
Financial Overview
FY2024
$4.97M
Total Assets
$1.80M
Total Liabilities
$13.01M
Stockholders' Equity
$-9.18
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-3 Shelf registration for future offerings | January 22, 2026 | View on SEC |
| 8-K Current report of material events | January 22, 2026 | View on SEC |
| 4/A Insider transaction amendment | January 22, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 21, 2026 | View on SEC |
| 8-K Current report of material events | January 20, 2026 | View on SEC |
| 4 Insider stock transaction report | December 15, 2025 | View on SEC |
| 4 Insider stock transaction report | December 15, 2025 | View on SEC |
| 4 Insider stock transaction report | December 15, 2025 | View on SEC |
| 4 Insider stock transaction report | December 15, 2025 | View on SEC |
| 4 Insider stock transaction report | December 15, 2025 | View on SEC |
Insider Trading
SELL 1 insiders
2 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.